Survey of Conflict-of-Interest Disclosure Policies of Ophthalmology Journals

Ophthalmology

Volumn 116, Issue 6, 2009, Pages 1093-1096

  Anraku, Ayako ^a   Jin, Ya Ping ^a,b   Trope, Graham E ^a   Buys, Yvonne M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTHOR; CONFLICT OF INTEREST; MEDICAL LITERATURE; MEDICAL RESEARCH; PEER REVIEW; POLICY; PRIORITY JOURNAL;

AUTHORSHIP; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DISCLOSURE; EDITORIAL POLICIES; HUMANS; LANGUAGE; OPHTHALMOLOGY; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC;

EID: 67349212348     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.053     Document Type: Article

References (32)

1. Thompson D.F. Understanding financial conflicts of interest. N Engl J Med 329 (1993) 573-576
2. Moses III H., and Martin J.B. Academic relationships with industry: a new model for biomedical research. JAMA 285 (2001) 933-935
3. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454-465
4. Buchkowsky S.S., and Jewesson P.J. Industry sponsorship and authorship of clinical trials over 20 years. Ann Pharmacother 38 (2004) 579-585
5. Patsopoulos N., Ioannidis J., and Analatos A. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 332 (2006) 1061-1064
6. Davidson R.A. Source of funding and outcome of clinical trials. J Gen Intern Med 1 (1986) 155-158
7. Rochon P.A., Gurwitz J.H., Simms R.W., et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 154 (1994) 157-163
8. Cho M.K., and Bero L.A. The quality of drug studies published in symposium proceedings. Ann Intern Med 124 (1996) 485-489
9. Friedberg M., Saffran B., Stinson T.J., et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282 (1999) 1453-1457
10. Djulbegovic B., Lacevic M., Cantor A., et al. The uncertainty principle and industry-sponsored research. Lancet 356 (2000) 635-638
11. Clifford T.J., Barrowman N.J., and Moher D. Funding source, trial outcome and reporting quality: are they related?. Results of a pilot study. BMC Health Services Res 2 (2002) 18. http://www.biomedcentral.com/1472-6963/2/18 Accessed December 16, 2008.
12. Kjaergard L.L., and Als-Nielsen B. Association between competing interests and author's conclusions: epidemiological study of randomized clinical trials published in the BMJ. BMJ 325 (2002) 249. http://www.bmj.com/cgi/content/full/325/7358/249 Accessed December 16, 2008.
13. Baker C.B., Johnsrud M.T., Crismon M.L., et al. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 183 (2003) 498-506
14. Lexchin J., Bero L.A., Djulbegovic B., and Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326 (2003) 1167-1170
15. Leopold S.S., Warme W.J., Fritz Braunlich E., and Shott S. Association between funding source and study outcome in orthopaedic research. Clin Orthop Relat Res 415 (2003) 293-301
16. Als-Nielsen B., Chen W., Gluud C., and Kjaergard L.L. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA 290 (2003) 921-928
17. Bhandari M., Busse J.W., Jackowski D., et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 170 (2004) 477-480
18. Finucane T.E., and Boult C.E. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med 117 (2004) 842-845
19. Shah R.V., Albert T.J., Bruegel-Sanchez V., et al. Industry support and correlation to study outcome for papers published in Spine. Spine 30 (2005) 1099-1104
20. Perlis R.H., Perlis C.S., Wu Y., et al. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162 (2005) 1957-1960
21. Yank V., Rennie D., and Bero L.A. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ 335 (2007) 1202-1205
22. Easterbrook P.J., Berlin J.A., Gopalan R., and Matthews D.R. Publication bias in clinical research. Lancet 337 (1991) 867-872
23. Dickersin K., Min Y.I., and Meinert C.L. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA 267 (1992) 374-378
24. Lynch J.R., Cunningham M.R., Warme W.J., et al. Commercially funded and United States-based research is more likely to be published; good-quality studies with negative outcomes are not. J Bone Joint Surg Am 89 (2007) 1010-1018
25. Alasbali T., Smith M., Geffen N., et al. Discrepancy between results and abstract conclusions in industry- versus nonindustry-funded studies comparing topical prostaglandins. Am J Ophthalmol 147 (2009) 33-38
26. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Updated October 2008. http://www.icmje.org Accessed August 1, 2008.
27. Journal Citation Reports, science ed [database]. Philadelphia, PA: Thomson Reuters. http://www.icmje.org Accessed August 1, 2008.
28. Krimsky S., and Rothenberg L.S. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 7 (2001) 205-218
29. Ancker J.S., and Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 13 (2007) 147-157
30. Haivas I., Schroter S., Waechter F., and Smith R. Editors' declaration of their own conflicts of interest. CMAJ 171 (2004) 475-476
31. Cooper R.J., Gupta M., Wilkes M.S., and Hoffman J.R. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med 21 (2006) 1248-1252
32. Lexchin J., and Light D.W. Commercial influence and the content of medical journals. BMJ 332 (2006) 1444-1447